Glycosylated fibronectin test in first trimester to predict chances of preeclampsia
Not Applicable
- Conditions
- Health Condition 1: O149- Unspecified pre-eclampsia
- Registration Number
- CTRI/2021/04/033066
- Lead Sponsor
- Dr Vomica Kewalramani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Multigravida with Gestational age-11-14 weeks with singleton pregnancy
Exclusion Criteria
K/c/o pre eclampsia
K/c/o gestational hypertension
K/c/o renal disease
K/c/o liver disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the potential clinical utility of serum biochemical marker glycosylated fibronectin for prediction of preeclampsia in first trimesterTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable